RCS - Inspiration Health - £1.3 million Iraq Order

Inspiration HealthcareAnnouncement

07/06/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220607:nRSG9080Na&default-theme=true

RNS Number : 9080N  Inspiration Healthcare Group PLC  07 June 2022

 

 

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

 

£1.3 million Iraq Order

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, is pleased to announce that it has received an order worth £1.3
million for the supply of SLE ventilators and Viomedex consumables to Iraq.
Part of the order has already been shipped after an initial payment was
received in March 2022 and the remainder of the order is expected to be
dispatched within the next few months.

The SLE ventilators are high-specification, sophisticated infant ventilators
offering a range of conventional modes with additional options for
non-invasive ventilation (NIV), high frequency oscillation ventilation (HFOV)
and high flow oxygen therapy.  They are used extensively in Neonatal
Intensive Care Units around the world to treat premature and sick babies.

Neil Campbell, Chief Executive Officer, commented: "We are delighted to
announce this sizeable order which again demonstrates the expansion of our
operations across new international markets and also the cross selling
opportunities which continue to be realised within the enlarged group."

 

Enquiries:

 

 Inspiration Healthcare Group plc                                                                                                                                                       Tel: +44 (0)330 175 0000

 Neil Campbell, Chief Executive Officer

 Jon Ballard, Chief Financial Officer
 Cadogan                                                                                                                                                                                Tel: 07771 713608
 PR

 Alex Walters

 alex.walters@cadoganpr.com (mailto:alex.walters@cadoganpr.com)

 

About Inspiration Healthcare Group

 

www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk/)

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in critical care & operating theatres. The Company provides
high-quality, innovative products to patients around the world which help to
improve patient outcomes, and it actively invests in innovative product
opportunities and disruptive technologies.

 

The Group currently consists of three companies: Inspiration Healthcare Ltd,
SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal
intensive care and operating theatre equipment around the work through a
network of distributors into over 75 countries.  Products range from highly
sophisticated capital equipment through to single use disposables all that can
help improve outcomes of extremely sick patients.

 

In the UK and Ireland the Group offers direct sales for most of its products
supported by Technical Service offering on site and return to base repair and
maintenance along with 24/7 emergency hire of equipment and long term lease
arrangements for its own brand products.  The Group also acts as a
distributor for 3(rd) party companies that wish to access the NHS using the
Group's sales and service expertise and knowledge of the NHS

 

The Group invests in growth through Research and Development holding numerous
patents on its technology and has strong links with academic Key Opinion
Leaders around the world and supports clinical research in the field of
neonatal intensive care.

 

Further information on Inspiration Healthcare Group plc can be seen
at  www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk/)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUNSWRUKUNRAR